Susquehanna International Group, LLP Pro Phase Labs, Inc. Transaction History
Susquehanna International Group, LLP
- $823 Billion
- Q3 2025
A detailed history of Susquehanna International Group, LLP transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 397,914 shares of PRPH stock, worth $119,374. This represents 0.0% of its overall portfolio holdings.
Number of Shares
397,914
Previous 102,015
290.05%
Holding current value
$119,374
Previous $39,000
348.72%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding PRPH
# of Institutions
30Shares Held
2.98MCall Options Held
13.7KPut Options Held
0-
Sykon Capital LLC Harrison, NY645KShares$193,4380.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA532KShares$159,5750.0% of portfolio
-
Geode Capital Management, LLC Boston, MA303KShares$90,8780.0% of portfolio
-
Accretive Wealth Partners, LLC Parsippany, NJ250KShares$75,0000.04% of portfolio
-
High Tower Advisors, LLC Chicago, IL237KShares$71,2010.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $4.81M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...